Ipsen, Santhera Agree On Fipamezole License Outside North America, Japan
Source: Morning Star
Friday 3rd September, 2010
The drug is under investigation for the treatment of dyskinesia in Parkinson's disease, with a first Phase III study scheduled for 2011, Ipsen said in a statement.
Under the agreement, the French bi... ...
Read the full story at
Morning Star
Email this story to a friend
Have your say on this story